Perilymph pharmacokinetics of markers and dexamethasone applied and sampled at the lateral semi-circular canal.
about
Intracochlear drug delivery in combination with cochlear implants : Current aspectsHearing Changes After Intratympanically Applied Steroids for Primary Therapy of Sudden Hearing Loss: A Meta-analysis Using Mathematical Simulations of Drug Delivery Protocols.[Intracochlear drug delivery in combination with cochlear implants : Current aspects].Perilymph pharmacokinetics of locally-applied gentamicin in the guinea pig.In vitro and in vivo pharmacokinetic study of a dexamethasone-releasing silicone for cochlear implants.[Local drug therapy for inner ear hearing loss].Controlled release dexamethasone implants in the round window niche for salvage treatment of idiopathic sudden sensorineural hearing lossSustained release of triamcinolone acetonide from an intratympanically applied hydrogel designed for the delivery of high glucocorticoid doses.Systemic lipopolysaccharide compromises the blood-labyrinth barrier and increases entry of serum fluorescein into the perilymph.Influence of cochleostomy and cochlear implant insertion on drug gradients following intratympanic application in Guinea pigsPrognostic Factors for Recovery from Sudden Sensorineural Hearing Loss: A Retrospective Study.Perilymph Kinetics of FITC-Dextran Reveals Homeostasis Dominated by the Cochlear Aqueduct and Cerebrospinal Fluid.Perilymph pharmacokinetics of marker applied through a cochlear implant in guinea pigs.Reduction of permanent hearing loss by local glucocorticoid application : Guinea pigs with acute acoustic trauma.[Reduction of permanent hearing loss by local glucocorticoid application : Guinea pigs with acute acoustic trauma. German version].Permeation Enhancers for Intratympanically-applied Drugs Studied Using Fluorescent Dexamethasone as a Marker.A Polymer-Based Extended Release System for Stable, Long-term Intracochlear Drug Delivery
P2860
Q30313632-42CAA57B-05D1-4FE1-97CA-3D5AA458015BQ30313800-713FF7E8-4496-41C8-9FEC-F85ED8B6CBFDQ30313814-ACA9D740-0318-45EE-8E8D-FCB6288F295CQ30313816-F209946B-5006-46F6-A7BF-6EF85869AD32Q30316230-C3717EA6-0523-4A28-84A3-5F146CE3A685Q30317246-0D45A651-30AE-4214-976C-F3F1A6BC3C77Q30317432-2CDBF3B2-4A58-41B6-A36E-7D77BD3EA764Q30392675-61E0664B-25F8-41C6-BAE2-99DF452A9B3DQ30401923-F498D857-C8BF-44FD-90CD-CC68B0793211Q30431310-7FB81B24-EEE2-4F8D-A0CC-4909E00AAF17Q33565822-4CD62C4D-7D9A-4B5B-8592-9AC6E9463656Q35561882-EC545795-EBB7-41F9-893A-569F0D049036Q38619862-8FBDE69B-44E2-4F87-8D0A-328FE3DE6BC1Q46407017-0A9BD3EA-B8C0-4F8F-9693-DB7ED9B133AAQ50315610-25706C75-9644-45AD-8C1C-11D3C1E603C6Q53693469-8D37E6D2-B375-4790-B065-B3F4E3933716Q57095355-62230F00-DBAA-426B-AEE6-190C19589F4D
P2860
Perilymph pharmacokinetics of markers and dexamethasone applied and sampled at the lateral semi-circular canal.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Perilymph pharmacokinetics of ...... e lateral semi-circular canal.
@ast
Perilymph pharmacokinetics of ...... e lateral semi-circular canal.
@en
type
label
Perilymph pharmacokinetics of ...... e lateral semi-circular canal.
@ast
Perilymph pharmacokinetics of ...... e lateral semi-circular canal.
@en
prefLabel
Perilymph pharmacokinetics of ...... e lateral semi-circular canal.
@ast
Perilymph pharmacokinetics of ...... e lateral semi-circular canal.
@en
P2093
P2860
P1433
P1476
Perilymph pharmacokinetics of ...... he lateral semi-circular canal
@en
P2093
Fabrice Piu
Jared J Hartsock
Ruth M Gill
Stefan K Plontke
P2860
P2888
P304
P356
10.1007/S10162-012-0347-Y
P50
P577
2012-09-12T00:00:00Z